Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro seems to wear off after five days, you are not imagining it. Appetite suppression and the feeling of fullness tend to be strongest in the first half of the weekly cycle, then soften in the days leading up to your next injection. This is a normal pattern linked to how tirzepatide moves through the body, not a sign the medicine has stopped working. Mounjaro is a prescription-only medicine; a clinician decides whether it is right for you and at what dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every medicine has a half-life: the time it takes for the concentration in your blood to fall by half. For tirzepatide, that figure sits at approximately five days. You inject once a week, so by day five your body has cleared roughly half the dose absorbed from the previous pen. Blood levels are at their peak in the day or two after injection, then follow a steady downward slope toward your next dose.
The practical result is that the appetite-suppressing effect tends to be most noticeable in the first half of the week and less pronounced toward the end. Some people barely register this. Others find days six and seven noticeably harder. Both experiences are within the normal range, and the NHS medicine information for tirzepatide does not list mid-week hunger as an adverse effect, because it is a pharmacological inevitability of a weekly drug, not a side effect. Understanding this pattern is the first step toward working with it rather than against it.
There is more detail on the broader pharmacology on our tirzepatide overview page, if you want the fuller picture of how this medicine works.
The question worth asking is whether what you are feeling is a predictable trough in the weekly cycle or something more persistent. A temporary return of appetite on days five through seven, followed by appetite settling again after your next injection, fits the first description. If hunger and cravings feel just as strong on day two as they did before you started (or if you are not losing weight at all over several months) that is a different conversation and one to have with your prescriber.
Tirzepatide is licensed in the UK for weight management as part of a reduced-calorie diet and increased physical activity. NICE's appraisal of tirzepatide (TA1026) notes that if someone loses less than five percent of their body weight after six months at their highest tolerated dose, continuing treatment should be reviewed. That review is a clinical decision, not one to make based on a rough week.
If you are uncertain which category you fall into, our frequently asked questions cover many of the common mid-treatment concerns people raise.
There are a few things within your control. Injection timing matters more than people expect. Injecting on the same day each week at roughly the same time keeps the overall pattern as stable as it can be. Many people settle into a routine around a fixed weekly moment, a Sunday evening before the week starts, or a Thursday morning before the commute. If your pen lives in the fridge door, pairing the injection with something you already do on that day makes forgetting less likely.
Protein and fibre at meals help with satiety independent of tirzepatide's effect. On the days when the medicine feels quieter, a higher-protein lunch or a glass of water before eating can make a noticeable difference. These are not substitutes for clinical management, but they are genuinely useful. Alcohol and high-fat meals can worsen nausea in the early days and may amplify GI symptoms if you are already sensitive.
For questions about storage windows, room-temperature limits, and what to do if a dose is delayed, the Mounjaro Patient Information Leaflet is the definitive reference, your prescriber and the leaflet itself should always be your first source for those specifics. Our page on whether Mounjaro wears off after five days addresses this in more depth, including what the pharmacokinetics look like across a typical week. If you have ever noticed the effect feeling different toward the end of a week and wondered whether that is just how the drug behaves, our guide on whether Mounjaro wears off after a few days explains the pattern clearly. It is also worth knowing that how long an open Mounjaro pen stays usable is a separate but related question, particularly if you find yourself adjusting your injection schedule.
If the mid-week drop is genuinely disruptive) if hunger on days five and six is derailing your eating patterns consistently, not just occasionally, that is worth raising at your next clinical review rather than managing alone. A prescriber may consider whether titration is appropriate, or whether there are other factors to address.
What a prescriber will not do is simply increase the dose because day six felt hard. Titration decisions are based on how well the current dose is tolerated, how weight is tracking over weeks and months, and the broader clinical picture. A question our prescribers hear regularly is whether switching to a different injection day could shift the difficult days away from a weekend or a social occasion. That is a reasonable practical question and worth raising.
If your treatment is currently managed elsewhere and you are thinking about transferring, our Mounjaro information page explains how the process works at nume. If you have not yet started and are considering your options, our weight-loss treatment overview sets out what is available. The cost side of things (what private treatment typically involves) is covered on our page on accessing Mounjaro privately. At the end of that, checking your eligibility with our prescribers is the natural next step if you want a clinical view on your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.